The Third National Hepatitis C Strategy 2010 - 2013

3. Objectives and indicators

Page last updated: July 2010

This section details objectives and indicators that will be used to monitor progress under the strategy. Indicators are measurable targets that apply to the related objective.

The primary indicators are those that have been agreed under the National Healthcare Agreement. These have been specified and will be regularly reported on during the life of the agreement. Additional indicators have been included for the more specific objectives relevant to this strategy. Further work will be undertaken during the implementation phase to develop a surveillance and monitoring plan. This will include further work on specifications for the indicators, and development of an agreed process for reporting on them. In some circumstances further data development may also be needed.


GOALOBJECTIVEINDICATOR(1)
Reduce the transmission of hepatitis CReduce the incidence of hepatitis CIncidence of hepatitis C (National Healthcare Agreement)
Increase access to new injecting equipment through needle and syringe programs (NSPs)Per capita rate of needles and syringes distributed in the public and pharmacy sector in the previous 12 months (National Healthcare Agreement)

Proportion of people who inject drugs and who report re-using another person’s used needle and syringe in the last month
Reduce the morbidity and mortality caused by hepatitis CReduce the burden of disease attributed to chronic hepatitis CEstimated number of people with hepatitis C infection by stage of liver disease:
  • chronic hepatitis C infection with stage F0/1 liver disease
  • chronic hepatitis C infection with stage F2/3 liver disease
  • living with hepatitis C-related cirrhosis.
Self-reported health status by people with hepatitis C
Increase access to clinical care for people with chronic hepatitis CProportion of people with chronic hepatitis C dispensed drugs for their infection through the Highly Specialised Drugs (s100) Program in the previous 12 months
Minimise the personal and social impact of hepatitis CReduce hepatitis C-related stigma and discrimination in healthcare settingsProportion of people with hepatitis C who report discrimination in healthcare settings
(1) In areas with available data